The Market Online - At The Bell

Join our daily newsletter At The Bell to receive exclusive market insights

This interview discusses Little Green Pharma’s (ASX:LGP) record-breaking quarterly results for June 2024, highlighting a 12% increase in revenue and significant cash receipts. CEO Paul Long elaborates on the company’s growth drivers, including new product sales in Australia and Europe, and outlines their strategy to maintain market share and expand in emerging European markets.

lgp by the numbers
More From The Market Online

Lunnon ramping up Lady Herial development after overcoming recent weather issues

Lunnon Metals has overcome recent weather issues and is preparing for the processing of the first…

Goldarc Resources secures strategic Kookynie tenement

GoldArc Resources has made a strategic acquisition to expand its Leonora South project footprint in Western…

Sun Silver kicks off four rig Maverick campaign

Sun Silver has mobilised four diamond core drill rigs as it accelerates drilling at the Maverick…
Ampol signange

Viva, Ampol both trade red ahead of expected Albo fuel rationing presser

If you’re brave enough to have raised your neck to survey the land of Australia’s finance news ecosystem on Wednesday, you already know